@PeterDLROW @C7RKY @legalaware @DocMartin68 #bigpharma are an interesting case, where commercial interests are a determinant of science
@PublicHealthSte @PeterDLROW @legalaware @DocMartin68 can't help but feel 'cures' are likely v unpopular w/ shareholders in such biz models
-
-
@C7RKY@PeterDLROW@legalaware@DocMartin68 I assume cost-benefit ratios are estimated at some point in the decision-making process? -
@PublicHealthSte@PeterDLROW@legalaware@DocMartin68 Sounds like a reasonable assumption to me... -
@C7RKY@PeterDLROW@legalaware@DocMartin68 Markets are indeed a strange mediator of human productivity, dont believe the hype. -
@PublicHealthSte@PeterDLROW@legalaware@DocMartin68 I accept very little on face value alone these days tbh. :)
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.